LAM
VRTX icon

LOM Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

LOM Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$699K Hold
1,565
– – 0.2% 114
2025
Q4 		$710K Hold
1,565
– – 0.21% 112
2025
Q3 		$613K Hold
1,565
– – 0.19% 120
2025
Q2 		$697K Buy
+1,565
New +$721K 0.24% 113

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

LOM Asset Management's VRTX Position: Q1 2026 in Review

LOM Asset Management held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 1,565 shares worth $699K. The position accounts for 0.2% of the portfolio, ranked #114.

LOM Asset Management first reported a position in VRTX in Q2 2025 and has held it in 4 quarters since. The position peaked at $710K in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • LOM Asset Management held 1,565 shares of Vertex Pharmaceuticals worth $699K as of Q1 2026.
  • LOM Asset Management left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up 0.2% of LOM Asset Management's portfolio in Q1 2026, its #114 holding.
  • LOM Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • LOM Asset Management's Vertex Pharmaceuticals position peaked at $710K in Q4 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on LOM Asset Management's 13F filing for Q1 2026, filed 5 May 2026.